Osteomol 665 and Panadol Osteo Availability

Page last updated: 10 April 2017

From 1 January 2016, certain products that are available for purchase over the counter are no longer available on the Pharmaceutical Benefits Scheme (PBS), including paracetamol 665mg modified release tablets. Consumers can continue to buy these medicines at competitive prices from pharmacies and, in some cases supermarkets, without a prescription.

Removing PBS subsidies for these products was recommended by the Pharmaceutical Benefits Advisory Committee (PBAC), an independent, expert advisory body, following consideration of submissions from suppliers and consumer groups.

The PBAC recommended maintaining certain paracetamol products on the PBS for Aboriginal and Torres Strait Islander people and palliative care patients because of the extraordinary health challenges faced by these groups.

Aboriginal and Torres Strait Islander people experience a burden of chronic diseases two-and-half times that of other Australians, including cardiovascular disease, diabetes, cancer, and chronic respiratory and kidney disease. Providing subsidies for products such as paracetamol 665mg modified release for Aboriginal and Torres Strait Islander people is helping to close the health and life expectancy gap between Aboriginal and Torres Strait Islander people and non-indigenous Australians